 |
 The Team
BEN WEINTRAUB, Ph.D.
Director of Research
After completing his training in immunology and biochemistry,
Dr. Weintraub began work as a financial analyst in 2000. Collaborating
with Dr. Henderson, Dr. Weintraub co-founded BiotechTracker,
an online tool for investors.
In 2004, he became a licensed
security analyst with Hibernia Southcoast Capital covering
the biotechnology sector, and later performed the same role
at Variant Research. In 2006, Dr. Weintraub joined Dr. Henderson
and Dr. Zuckerman at Reuters Insight, providing analysis of
drug development and trends in medicine to professional investors.
Dr. Weintraub’s team moved to Wolters Kluwer in January 2009.
Prior to 2000, Dr. Weintraub was senior scientific editor for
the biology research journals Cell and Molecular
Cell. Dr. Weintraub performed biochemistry and immunology
research at Stanford University and at the John Curtin School
of Medical Research in Canberra, Australia. He earned his doctorate
in Biology from the University of California, San Diego, and
a bachelor of science in Life Science from the Massachusetts
Institute of Technology.
|
|
